1. Home
  2. TENX vs CSTE Comparison

TENX vs CSTE Comparison

Compare TENX & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$2.13

Market Cap

71.1M

Sector

Health Care

ML Signal

N/A

CSTE

Caesarstone Ltd.

N/A

Current Price

$3.14

Market Cap

76.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
CSTE
Founded
1967
1987
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
71.1M
76.4M
IPO Year
2001
2012

Fundamental Metrics

Financial Performance
Metric
TENX
CSTE
Price
$2.13
$3.14
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
9.0M
125.4K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.43
Revenue Next Year
N/A
$2.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.56
52 Week High
$19.40
$3.84

Technical Indicators

Market Signals
Indicator
TENX
CSTE
Relative Strength Index (RSI) 23.92 62.13
Support Level $1.31 $1.79
Resistance Level $14.15 N/A
Average True Range (ATR) 0.20 0.28
MACD 0.17 -0.01
Stochastic Oscillator 75.00 56.34

Price Performance

Historical Comparison
TENX
CSTE

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa), of which it derives maximum revenue from United States.

Share on Social Networks: